These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1034 related items for PubMed ID: 9377571

  • 1. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J.
    Cancer Res; 1997 Oct 15; 57(20):4570-7. PubMed ID: 9377571
    [Abstract] [Full Text] [Related]

  • 2. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 3. HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy.
    Fauquembergue E, Toutirais O, Tougeron D, Drouet A, Le Gallo M, Desille M, Cabillic F, de La Pintière CT, Iero M, Rivoltini L, Baert-Desurmont S, Leprince J, Vaudry H, Sesboué R, Frébourg T, Latouche JB, Catros V.
    J Immunother; 2010 May 15; 33(4):402-13. PubMed ID: 20386466
    [Abstract] [Full Text] [Related]

  • 4. Differential gene expression profiles in a human T-cell line stimulated with a tumor-associated self-peptide versus an enhancer agonist peptide.
    Palena C, Schlom J, Tsang KY.
    Clin Cancer Res; 2003 May 15; 9(5):1616-27. PubMed ID: 12738714
    [Abstract] [Full Text] [Related]

  • 5. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL, Crew MD, Santin AD, O'Brien TJ, Cannon MJ.
    Clin Cancer Res; 2005 May 01; 11(9):3446-54. PubMed ID: 15867247
    [Abstract] [Full Text] [Related]

  • 6. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.
    Huarte E, Sarobe P, Lu J, Casares N, Lasarte JJ, Dotor J, Ruiz M, Prieto J, Celis E, Borrás-Cuesta F.
    Clin Cancer Res; 2002 Jul 01; 8(7):2336-44. PubMed ID: 12114438
    [Abstract] [Full Text] [Related]

  • 7. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen.
    Terasawa H, Tsang KY, Gulley J, Arlen P, Schlom J.
    Clin Cancer Res; 2002 Jan 01; 8(1):41-53. PubMed ID: 11801539
    [Abstract] [Full Text] [Related]

  • 8. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    Cancer; 2009 Feb 15; 115(4):800-11. PubMed ID: 19117353
    [Abstract] [Full Text] [Related]

  • 9. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P.
    Cancer Res; 1997 Feb 15; 57(4):735-41. PubMed ID: 9044853
    [Abstract] [Full Text] [Related]

  • 10. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
    Takahashi T, Irie RF, Nishinaka Y, Hoon DS.
    Clin Cancer Res; 1997 Aug 15; 3(8):1363-70. PubMed ID: 9815820
    [Abstract] [Full Text] [Related]

  • 11. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
    Bergmann-Leitner ES, Kantor JA, Shupert WL, Schlom J, Abrams SI.
    Cell Immunol; 1998 Aug 01; 187(2):103-16. PubMed ID: 9732698
    [Abstract] [Full Text] [Related]

  • 12. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
    Bae J, Martinson JA, Klingemann HG.
    Clin Cancer Res; 2005 Feb 15; 11(4):1629-38. PubMed ID: 15746068
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.
    Tsang KY, Zhu M, Nieroda CA, Correale P, Zaremba S, Hamilton JM, Cole D, Lam C, Schlom J.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2439-49. PubMed ID: 9815645
    [Abstract] [Full Text] [Related]

  • 14. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ, Chan HW, Karbach J, Salter RD, Knuth A, Lotze MT, Storkus WJ.
    Eur J Immunol; 1996 Nov 15; 26(11):2613-23. PubMed ID: 8921947
    [Abstract] [Full Text] [Related]

  • 15. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen.
    van Elsas A, van der Burg SH, van der Minne CE, Borghi M, Mourer JS, Melief CJ, Schrier PI.
    Eur J Immunol; 1996 Aug 15; 26(8):1683-9. PubMed ID: 8765006
    [Abstract] [Full Text] [Related]

  • 16. Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses.
    Eguchi J, Hatano M, Nishimura F, Zhu X, Dusak JE, Sato H, Pollack IF, Storkus WJ, Okada H.
    Cancer Res; 2006 Jun 01; 66(11):5883-91. PubMed ID: 16740728
    [Abstract] [Full Text] [Related]

  • 17. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI, Khleif SN, Bergmann-Leitner ES, Kantor JA, Chung Y, Hamilton JM, Schlom J.
    Cell Immunol; 1997 Dec 15; 182(2):137-51. PubMed ID: 9514698
    [Abstract] [Full Text] [Related]

  • 18. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
    Lu J, Celis E.
    Cancer Res; 2000 Sep 15; 60(18):5223-7. PubMed ID: 11016651
    [Abstract] [Full Text] [Related]

  • 19. Recognition of carcinoembryonic antigen peptide and heteroclitic peptide by peripheral blood T lymphocytes.
    Brown ME, Miao H, McKee MD.
    J Immunother; 2007 Apr 15; 30(3):350-8. PubMed ID: 17414326
    [Abstract] [Full Text] [Related]

  • 20. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
    Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E.
    J Immunol; 1995 Mar 01; 154(5):2257-65. PubMed ID: 7868898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.